Inventor
SCHULER GEROLD
AT18 patents
⚠️ This page may combine multiple inventors who share the name “SCHULER GEROLD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHULER GEROLD
6 patentsUS8236562B2Aug 7, 2012
Method for producing ready to use, antigen-loaded or unloaded, cryoconserved mature dendritic cells
SCHULER GEROLD8 citations78
US10006901B2Jun 26, 2018
CD4+CD25+ regulatory T cells from human blood
SCHULER GEROLD2 citations68
US8574901B2Nov 5, 2013
Cryoconserved mature dendritic cells
SCHULER GEROLD3 citations57
US8603815B2Dec 10, 2013
CD4+ CD25− T cells and Tr1-like regulatory T cells
SCHULER GEROLD0 citations47
US8222033B2Jul 17, 2012
CD4+CD25− T cells and Tr1-like regulatory T cells
SCHULER GEROLD0 citations47
US8076134B2Dec 13, 2011
CD4+CD25− T cells and Tr1-like regulatory T cells
SCHULER GEROLD0 citations47
UNIV ROCKEFELLER
3 patentsUS6274378B1Aug 14, 2001
Methods and compositions for obtaining mature dendritic cells
UNIV ROCKEFELLER149 citations98
US5994126ANov 30, 1999
Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
UNIV ROCKEFELLER251 citations98
US5851756ADec 22, 1998
Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
UNIV ROCKEFELLER121 citations98
ARGOS THERAPEUTICS INC
3 patentsUS7198948B2Apr 3, 2007
Methods and compositions for obtaining mature dendritic cells
ARGOS THERAPEUTICS INC10 citations83
US7659119B2Feb 9, 2010
Method and compositions for obtaining mature dendritic cells
ARGOS THERAPEUTICS INC3 citations62
US7923247B2Apr 12, 2011
Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
ARGOS THERAPEUTICS INC0 citations51
UNIV FRIEDRICH ALEXANDER ER
3 patentsUS12152247B2Nov 26, 2024
NF-KB signaling pathway-manipulated dendritic cells
UNIV FRIEDRICH ALEXANDER ER0 citations54
US11466289B2Oct 11, 2022
NF-KB signaling pathway-manipulated dendritic cells
UNIV FRIEDRICH ALEXANDER ER0 citations54
US10851402B2Dec 1, 2020
Method for in vitro detection and monitoring of a disease by measuring disease-associated protease activity in extracellular vesicles
UNIV FRIEDRICH ALEXANDER ER0 citations37